Table 5.

Characteristics of women showing residual/recurrent cervical intraepithelial neoplasia (CIN)-2/3 after treatment

No.	Age (yr)	Parity	Menopause	HPV loada)	HPV Type	Treatment	Cytology	Pathology	RM	GI	Follow up				Time to diagnosis of residual/recurrent CIN 2/3 (mon)
											HPV	Type change	Cytology	Path
1	25	0	No	+++	161,833	Cone	ASCUS	CIN 2	-	-	161,833	-	HSIL	CIN2	11.7
2	27	0	No	+++	3,339	LEEP	ASCUS	CIN 3	+	-	16	+	LSIL	CIN3	8.4
3	27	0	No	++	52	Cone	HSIL	CIN 3	+	+	52	-	ASCUS	CIN3	9.3
4	38	1	No	++	1,618	LEEP	ASCUS	CIN 3	-	+	183,553	-	ASCUS	CIN2	23.1
5	40	2	No	++	33	Cone	HSIL	CIN 3	+	+	33	-	HSIL	CIN3	13.3
6	41	2	No	++	33	Cone	HSIL	CIN 3	-	+	3,556	+	ASCUS	CIN2	12.5
7	42	1	No	+++	31	Cone	LSIL	CIN 3	+	+	3,159	-	HSIL	CIN3	7.7
8	45	4	No	+++	16	Cone	HSIL	CIN 3	-	+	16	-	HSIL	CIN3	9.5
9	49	1	No	++	5,868	Cone	HSIL	CIN 3	-	-	5,868	-	HSIL	CIN3	2.1
10	52	2	Yes	++	31	Cone	HSIL	CIN 3	+	+	31	-	ASCUS	CIN3	13.3
11	56	2	Yes	++	5,358	LEEP	HSIL	CIN 2	-	-	5,358	-	LSIL	CIN2	4.4
12	56	2	Yes	+++	16	Cone	HSIL	CIN 2	-	-	16	-	ASCUS	CIN3	6.7
13	57	2	Yes	++	1,635	LEEP	SCC	CIN 3	-	-	1,635	-	HSIL	CIN2	4.3
14	59	2	Yes	++	3,352	LEEP	HSIL	CIN 3	-	-	3,352	-	HSIL	CIN3	5.7
15	63	3	Yes	+	45	LEEP	HSIL	CIN 3	-	+	45	-	HSIL	CIN3	4.7

HPV, human papillomavirus; RM, resection margin; GI, glandular involvement; Path, pathology; Cone, conization; ASCUS, atypical squamous cells of undetermined significance; HSIL, high-grade intraepithelial lesion; LEEP, loop electrosurgical excision procedure; LSIL, low-grade intraepithelial lesion; SCC, squamous cell carcinoma.

^a)HPV viral copy number. +, <10²; ++, 10²–10⁵; +++, >10⁵.